Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last --
Change Today 0.00 / 0.00%
Volume 0.0
8120 On Other Exchanges
Symbol
Exchange
8120 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Rui Lin Song

AgeTotal Calculated CompensationThis person is connected to 13 board members in 1 different organizations across 2 different industries.

See Board Relationships
52--

Background*

Mr. Rui Lin Song serves as Executive Director-General of the China Pharmaceutical Association's Research Center for Medicinal Policy and Chairman of the Chinese Journal of New Drugs. Mr. Song serves as Director of Epitomics, Inc. Mr. Song served as Member of the International Advisory committee of Oriental Unicorn Agricultural Group Limited and China Medical and Bio Science Limited (formerly, China Medical Science Limited). Mr. Song has years of experience and expertise ...

Read Full Background

Corporate Headquarters*

Unit A, Nathan Tower
Yau Ma Tei, Kowloon --

Hong Kong

Phone: 852 2116 1218
Fax: 852 2151 1872

Board Members Memberships*

Director

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
8120:HK $0.10 HKD +0.002

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHINA DEMETER INVESTMENTS LT, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.